Advertisement
News
Subscribe to MDT Magazine News

Treatment for Prescription Drug Addiction and Painkiller Abuse has Risen Sharply Since Onset of Financial Crisis, Reflecting Uncertainty About Economy

February 9, 2011 10:36 am | by Bio-Medicine.Org | Comments

MALIBU, Calif., Feb. 9, 2011 /- The 2007 onset of the financial crisis that upended the U.S. economy and impacted global markets correlated closely with unprecedented numbers of patients seeking treatment for prescription drug addiction and painkiller abuse, according to leading...

TOPICS:

PeriGen, Inc. Forms Strategic Alliance with Willis Healthcare to Improve Quality of Care in OB

February 9, 2011 10:36 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., Feb. 9, 2011 /- PeriGen, Inc., the only OB-specific risk reduction company to provide solutions which generate immediate quantifiable clinical and financial value, today announced the formation of a strategic alliance with Willis Group Holdings (NYSE: WSH ), a leading...

TOPICS:

Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS

February 9, 2011 10:34 am | by Bio-Medicine.Org | Comments

ROCKVILLE, Md., Feb. 9, 2011 /- Neuralstem, Inc. (NYSE Amex: CUR ) announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted it orphan drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS) with its human spinal cord...

TOPICS:
Advertisement

Arstasis One Access System: Class I Recall - Components May Fracture and/or Separate

February 9, 2011 9:30 am | by U.S. Food & Drug Administration | Comments

Use of recalled product may lead to patient harm.

TOPICS:

Analyst predicts flat initial Medicare rates

February 9, 2011 7:45 am | by The Associated Press | Comments

Initial 2012 reimbursement rates for Medicare Advantage plans should be roughly flat, which tops the consensus expectation of a 2 percent drop, according to Citi analyst Carl McDonald.McDonald said Tuesday in a research note the rates will be hurt by cuts from the health care overhaul, but he...

Rock Creek Pharmaceuticals Discloses Filing of Provisional Patent Application For Isolated Anatabine Isomer

February 9, 2011 7:36 am | by Bio-Medicine.Org | Comments

GLEN ALLEN, Va., Feb. 9, 2011 /- Rock Creek Pharmaceuticals, a subsidiary of Star Scientific, Inc. (Nasdaq: CIGX ) announced that on February 4 a provisional patent application was filed with the Patent and Trademark Office ("PTO") for administering a pure form of a single isomer of...

TOPICS:

Now Available: Archived Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices

February 9, 2011 7:36 am | by Bio-Medicine.Org | Comments

LOS ANGELES, Feb. 9, 2011 /- Design Trends: Technological Advances in Implantable Devices, a UBM Canon Medical Device Media Group virtual event hosted by Medical Device and Diagnostic Industry ( MD+DI ) , Medical Product Manufacturing News ( MPMN) , and OrthoTec , is now on-demand until...

TOPICS:

UK & #8217;s Favourite TV Doctor To & #8216;Kiss Off & #8217;

February 9, 2011 7:35 am | by RealWire | Comments

Blue Lip World Record Breaker To Boost Profile Of Rare Deadly Lung Disease The UK's Popular TV medic, Dr Chris Steele MBE, is launching the final stage of an innovative, charity led, global health education campaign on February 18th 2011 at a North West England High School that looks set...

TOPICS:
Advertisement

BD and UCL Business Reach Exclusive License Agreement to Advance Development of New Diagnostic Tests for Ovarian and Breast Cancers

February 9, 2011 7:35 am | by Bio-Medicine.Org | Comments

LONDON and FRANKLIN LAKES, N.J., Feb. 9, 2011 /- UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of...

TOPICS:

Extenway Terminals Featured in Leading Healthcare Journal

February 9, 2011 6:45 am | by The Associated Press | Comments

Extenway Solutions (TSX VENTURE: EY) is pleased to announce that its bedside terminals are the focus of a full-page article in the latest edition of Healthcare Information Management & Communications Canada, a highly-regarded industry publication with a reach of 13 000.The article, which...

Genomic Health turns 4Q, full-year 2010 profit

February 9, 2011 5:45 am | by The Associated Press | Comments

Clinical diagnostic test developer Genomic Health Inc. turned a fourth-quarter profit as it saw a 14 percent increase in the number of Onco type DX test results delivered.The Redwood City, Calif., company said late Tuesday it earned $1.7 million, or 6 cents per share, in the three months that...

Allied Healthcare 1Q profit hit by UK budget cuts

February 9, 2011 5:45 am | by The Associated Press | Comments

British health care staffing company Allied Healthcare International Inc. said Wednesday its profit dropped 36 percent in the fiscal first quarter as the British government reduced its public spending.In the three months ended Dec. 31, Allied said its profit fell to $1.8 million, or 4 cents per...

IBM Business Analytics Helps Sequoia Hospital Cut Mortality Rates in Cardiac Surgery by 50 Percent

February 9, 2011 5:33 am | by IBM | Comments

IBM today announced that Sequoia Hospital, based in Redwood City, Calif., has reduced its mortality rate in cardiac surgeries more than 50 percent through the use of IBM predictive analytics software by reducing risk and offering personalized patient care. E-mail this page Save to...

TOPICS:

Experts call for greater awareness of the links between diabetes and kidney disease

February 9, 2011 5:33 am | by EurekAlert | Comments

(Wiley-Blackwell) Experts are calling for greater awareness of the kidney problems that diabetics can face, after research found that awareness was low among white and South Asian patients. The first time that many patients realized that diabetes could affect their kidneys was when they...

TOPICS:

Computational biotech CMD Bioscience finds financing

February 9, 2011 5:33 am | by Mass High Tech: The Journal of New England Technology | Comments

CMD Bioscience LLC, a computational biotechnology firm in Orange, Conn., has taken in $150,000 of a planned $225,000 mixed offering of equity, debt, warrants and options, according to a regulatory filing.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading